Search Within

Joachim Yahalom

Formats
  1. Journal Article (281)
  2. Meeting Abstract (243)
  3. Book Section (67)
  4. Review (9)
  5. Conference Paper (6)
  6. Research Letter (6)
  7. Guidelines (5)
  8. Correspondence (4)
  9. Editorial (3)
  10. Book Whole (1)
Groups
  1. Radiation Oncology, Department of (625)
  2. Survivorship Research (625)
  3. Department of Medicine (283)
  4. Hematologic Malignancies, Division of (277)
  5. Center for Hematologic Malignancies (248)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Brandon Imber (116)
  3. Craig Moskowitz (87)
  4. David Straus (82)
  5. Carla Hajj (73)
  6. Ariela Noy (71)

More People

Years
  1. 2025 (9)
  2. 2024 (26)
  3. 2023 (48)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (24)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (125)
  2. Blood (96)
  3. Journal of Clinical Oncology (46)
  4. Hematological Oncology (34)
  5. Journal of the National Comprehensive Cancer Network (31)
  6. Leukemia and Lymphoma (17)

More Publications

Publishers
  1. Elsevier Inc. (161)
  2. American Society of Hematology (105)
  3. American Society of Clinical Oncology (46)
  4. Wiley Blackwell (43)
  5. Harborside Press (31)
  6. Lippincott Williams & Wilkins (28)

More Publishers

Results (625)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic and therapeutic considerations for extramedullary leukemia
    Review

    Bakst, R.; Powers, A.; Yahalom, J.
    Current Oncology Reports (2020)

    Fulltext@MSK | Save
  • Radiotherapy for non-Hodgkin lymphomas
    Review

    Imber, B. S.; Yahalom, J.
    The Cancer Journal (2020)

    Fulltext@MSK | Save
  • Principles of radiation therapy for Hodgkin lymphoma
    Journal Article

    Yahalom, J.; Hoppe, B. S.; Yang, J. C.; Hoppe, R. T.
    Hematologic Malignancies (2020)

    Fulltext@MSK | Save
  • Rosai-Dorfman disease - Utility of (18)F-FDG PET/CT for initial evaluation and follow-up
    Journal Article

    Mahajan, S.; Nakajima, R.; Yabe, M.; Dogan, A.; Ulaner, G. A.; Yahalom, J.; Noy, A.; Diamond, E. L.; Schòˆder, H.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease
    Journal Article

    Qi, S.; Milgrom, S.; Dabaja, B.; Tsang, R.; Levis, M.; Ricardi, U.; Lopez-Alonso, R.; Dann, E. J.; Ng, A.; Yahalom, J.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
    Guidelines

    Yahalom, J.; Dabaja, B. S.; Ricardi, U.; Ng, A.; Mikhaeel, N. G.; Vogelius, I. R.; Illidge, T.; Qi, S.; Wirth, A.; Specht, L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Deauville dubiosity
    Correspondence

    Yang, J. C.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Making every single gray count: Involved site radiation therapy delineation guidelines for hematological malignancies
    Editorial

    Dabaja, B. S.; Ng, A. K.; Terezakis, S. A.; Plastaras, J. P.; Yunes, M.; Wilson, L. D.; Specht, L.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Highly favorable outcomes with salvage radiation therapy followed by autologous transplant in relapsed and refractory DLBCL patients with minimal or no response to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term follow-up confirms durability of single-agent brentuximab vedotin as pre-transplant salvage for classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Schoder, H.; Lee, J.; Davey, T.; Hancock, H.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; Noy, A.; more...
    Blood (2019)

    Fulltext@MSK | Save